Israel’s D-Pharm has begun Phase 2 testing in the Ukraine of its THR-18 treatment for patients suffering from blood clots and strokes.
http://www.dpharm.com/news.asp?year=2013&type=0&mode=1&id=143
Trials start on blood clot treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.